Literature DB >> 6812428

Endocrinologic milieu and susceptibility of the rat mammary gland to carcinogenesis.

D R Ciocca, A Parente, J Russo.   

Abstract

The incidence of DMBA-induced mammary carcinomas in Sprague-Dawley rats depends upon their previous reproductive histories. Young virgin rats (YV) are highly susceptible to the carcinogen, while old virgin rats (OV) are less susceptible, and parous rats (P) are resistant. The authors performed endocrinologic studies in these three groups of rats in order to determine whether the different susceptibility to carcinogenesis, according to the reproductive history, is or is not related to the hormonal milieu. The pituitary, the ovaries, the adrenals, and the mammary glands were processed for light microscopy. Pituitary prolactin (PRL), follicle-stimulating hormone, and luteinizing hormone cells were immunostained by peroxidase-antiperoxidase and quantitated with an image analyzer. Radioimmunoassays of serum and pituitary PRL and serum estradiol were also done. The results showed no differences in the hormonal milieu of YV, OV, and P rats at the time of carcinogen treatment. Several changes were observed after DMBA administration, the most conspicuous being 1) hyperplasia of pituitary PRL cells, 2) high serum PRL levels, 3) nodular hyperplasia of the adrenal cortex, 4) high serum estradiol levels, and 5) lack of adrenal necrosis in P rats and some OV rats. These modifications did not correlate with the degree of susceptibility of YV, OV, and P rats to carcinogenesis, supporting the concept of the importance of the mammary gland differentiation at the moment of carcinogen administration. (Am J Pathol 1982, 109:47-56).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812428      PMCID: PMC1916060     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis.

Authors:  J Russo; I H Russo
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

2.  Classifications of anterior pituitary cell types with immunoenzyme histochemistry.

Authors:  P K Nakane
Journal:  J Histochem Cytochem       Date:  1970-01       Impact factor: 2.479

3.  Relationship between previous reproductive history and chemically induced mammary cancer in rats.

Authors:  R C Moon
Journal:  Int J Cancer       Date:  1969-05-15       Impact factor: 7.396

4.  Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene.

Authors:  I H Russo; J Russo
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

5.  Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.

Authors:  J Russo; G Wilgus; I H Russo
Journal:  Am J Pathol       Date:  1979-09       Impact factor: 4.307

6.  Prolactin and murine mammary tumorigenesis: a review.

Authors:  C W Welsch; H Nagasawa
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

7.  Role of adrenals and estrogen in regression of mammary tumors during postpartum lactation in the rat.

Authors:  C F Aylsworth; C A Hodson; G Berg; G Kledzik; J Meites
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

8.  An ultrastructural, morphometric and autoradiographic study of the effects of 7,12-dimethylbenzanthracene on the rat adrenal cortex.

Authors:  A S Belloni; G Mazzocchi; C Robba; A M Gambino; G G Nussdorfer
Journal:  Virchows Arch B Cell Pathol       Date:  1978-01-18

9.  [Alteration in the secretion of anterior pituitary hormones during dimethylbenzathracene induction of mammary tumors in rats].

Authors:  A El Abed; M Valens; Y Langlois; B Kerdelhue
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1977-12-19

10.  7,12-dimethylbenz[a]anthracene-induced DNA binding and repair synthesis in susceptible and nonsusceptible mammary epithelial cells in culture.

Authors:  L K Tay; J Russo
Journal:  J Natl Cancer Inst       Date:  1981-07       Impact factor: 13.506

View more
  9 in total

1.  4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats.

Authors:  Laura E Wright; Jennifer B Frye; Ashley L Lukefahr; Samuel L Marion; Patricia B Hoyer; David G Besselsen; Janet L Funk
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

2.  Constitution and behavior of follicular structures in the human anterior pituitary gland.

Authors:  D R Ciocca; L A Puy; A O Stati
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

Review 3.  Role of hormones in mammary cancer initiation and progression.

Authors:  I H Russo; J Russo
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

4.  Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol.

Authors:  I H Russo; J Frederick; J Russo
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

Review 5.  Experimentally induced mammary tumors in rats.

Authors:  J Russo; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 6.  Mammary gland neoplasia in long-term rodent studies.

Authors:  I H Russo; J Russo
Journal:  Environ Health Perspect       Date:  1996-09       Impact factor: 9.031

7.  Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.

Authors:  I H Russo; P Gimotty; M Dupuis; J Russo
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

Review 8.  Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; D R Ciocca; I H Russo
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

9.  Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis.

Authors:  I H Russo; M Koszalka; J Russo
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.